Laura D. Hover
Laura D. Hover publishes mostly in Molecular Biology, Genetics and Oncology, on topics such as Glioma Diagnosis and Treatment, TGF-β signaling in diseases and Colorectal Cancer Treatments and Studies.
- World rank
- #452,549 of 7,710,434 ranked researchers
- Rank in United States
- #158,909 of 1,627,098
- Works
- 137
- Citations
- 1.1k
- Citations per work
- 8.2
What does Laura D. Hover research?
Laura D. Hover's work is mostly in Biochemistry, Genetics and Molecular Biology (47%), Medicine (35%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Life Sciences6447.0%
- Health Sciences4835.4%
- Medicine4835.4%
- Everything else2417.6%
- 1Molecular Biology36% of their works
- 2Genetics16% of their works
- 3Oncology14% of their works
- 4Cancer Research6% of their works
- 5Pulmonary and Respiratory Medicine6% of their works
- 6Biotechnology4% of their works
Research topics
Which keywords describe Laura D. Hover's research?
The keywords of their largest research topics: Immunotherapy, Glioblastoma, Temozolomide, Smad-dependent pathways, Tumor Suppression, Cetuximab, KRAS Mutations and Bacterial Therapy.
- Bioimage Analysis
- Protein Arginine Methyltransferases
- EGFR Mutations
- Arginine Methylation
- Bacterial Therapy
- Cetuximab
- Smad-dependent pathways
- Glioblastoma
- Immunotherapy
- Temozolomide
- Tumor Suppression
- KRAS Mutations
- Tumor Targeting
- DNA Methylation
- Histone Modification
- Targeted Therapy
- High-Content Screening
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 17 words, with their numbers
- Immunotherapy182 topics
- Glioblastoma141 topic
- Temozolomide141 topic
- Smad-dependent pathways61 topic
- Tumor Suppression61 topic
- Cetuximab51 topic
- KRAS Mutations51 topic
- Bacterial Therapy41 topic
- Tumor Targeting41 topic
- Arginine Methylation31 topic
- DNA Methylation31 topic
- EGFR Mutations31 topic
- Histone Modification31 topic
- Protein Arginine Methyltransferases31 topic
- Targeted Therapy31 topic
- Bioimage Analysis21 topic
- High-Content Screening21 topic
Where does Laura D. Hover work?
Laura D. Hover's main affiliation in the publication record is Mirati Therapeutics (United States), United States.
How many publications and citations does Laura D. Hover have?
OpenAlex counts 137 works and 1,122 citations for Laura D. Hover, an h-index of 16, ranking #452,549 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Laura D. Hover. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.